PB
Invesco Biotechnology & Genome ETF (PBE)
NYSE
97.30
-0.29 (-0.30%)
Closed
Aug 24, 2026
Day's Range
96.6497.71
52 wk Range
67.4198.32
Overview - PBE - Invesco Biotechnology & Genome ETF
Key Statistics
Valuation
P/E (Trailing)
‪26.26‬
Price stats
50-Day Avg
‪90.57‬
200-Day Avg
‪83.28‬
Dividends
Frequency
Annual
Market Cap - PBE - Invesco Biotechnology & Genome ETF
Peers - PBE - Invesco Biotechnology & Genome ETF
Peer Comparison
Compared with other ETFs.
- PBENYSEInvesco Biotechnology & Genome ETF363.17MMarket Cap+30.75%52-week change26.26P/E (Trailing)—Profit Margin
- IVVNYSEiShares Core S&P 500 ETF446.58BMarket Cap+16.07%52-week change25.79P/E (Trailing)—Profit Margin
- FIFIYYNYSEGraniteShares YieldBOOST Single Stock Universe ETF241.84BMarket Cap-1.95%52-week change—P/E (Trailing)—Profit Margin
- IWIWFNYSEiShares Russell 1000 Growth ETF135.91BMarket Cap+7.65%52-week change31.31P/E (Trailing)—Profit Margin
- GLDNYSESPDR Gold Shares112.77BMarket Cap+27.39%52-week change—P/E (Trailing)—Profit Margin
- EFANYSEiShares MSCI EAFE ETF95.13BMarket Cap+15.00%52-week change19.06P/E (Trailing)—Profit Margin
- IEIEMGNYSEiShares Core MSCI Emerging Markets ETF89.95BMarket Cap+22.23%52-week change17.46P/E (Trailing)—Profit Margin
Profile Summary - PBE - Invesco Biotechnology & Genome ETF
About
The Invesco Biotechnology & Genome Fund is an exchange-traded fund (ETF) that primarily focuses on the biotechnology sector, providing investors exposure to companies engaged in the research and development of genetic and biological innovations. Its primary function is to track the performance of the Dorsey Wright®…
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
